Abstract：
Our systematic review highlights that multiparametric PAI score assessment is a consistent tool with high sensitivity and specificity for prenatal prediction for placenta accreta spectrum (PAS) in high-risk population with anterior placenta previa or low-lying placenta and prior cesarean deliveries. A systematic search was conducted on November 1, 2022, of MEDLINE via PubMed, Scopus, Web of Science Core Collection, Cochrane Library, and Google Scholar to identify relevant studies (PROSPERO ID # CRD42022368211). A total of 11 articles met our inclusion criteria, representing the data of a total of 1,044 cases. Women with PAS had an increased mean PAI total score, compared to those without PAS. Limitations of the PAI are most studies were conducted in developing countries in high-risk population which limit the global generalizability of findings. Heterogeneity of reported data did not allow to perform meta-analysis.
摘要：
我们的系统评价强调，多参数PAI评分评估是一种一致的工具，具有很高的敏感性和特异性，可用于胎盘植入谱（PAS）的产前预测，包括前置胎盘或胎盘低洼和剖宫产的高危人群。2022年11月1日，通过PubMed对MEDLINE进行了系统搜索，Scopus,WebofScience核心合集,科克伦图书馆,和谷歌学者确定相关研究(PROSPEROID#CRD42022368211)。共有11篇文章符合我们的纳入标准，代表总共1044例病例的数据。患有PAS的女性平均PAI总分增加，与没有PAS的人相比。PAI的局限性是大多数研究是在高风险人群的发展中国家进行的，这限制了研究结果的全球普遍性。报告数据的异质性不允许进行荟萃分析。
